Order Article Reprints

Nemeckova S, Alexova-Zurkova K, Hainz P, Krystofova J, Mackova J, Roubalova K, Stastna-Markova M, Vrana M, Vydra J. Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor. Current Oncology. 2022; 29(5):2928-2934. https://doi.org/10.3390/curroncol29050239

Nemeckova, Sarka, Kamila Alexova-Zurkova, Petr Hainz, Jitka Krystofova, Jana Mackova, Katerina Roubalova, Marketa Stastna-Markova, Milena Vrana, and Jan Vydra. 2022. "Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor" Current Oncology 29, no. 5: 2928-2934. https://doi.org/10.3390/curroncol29050239

Nemeckova, S., Alexova-Zurkova, K., Hainz, P., Krystofova, J., Mackova, J., Roubalova, K., Stastna-Markova, M., Vrana, M., & Vydra, J. (2022). Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor. Current Oncology, 29(5), 2928-2934. https://doi.org/10.3390/curroncol29050239